RELIEF THERAPEUTICS N/ CH1251125998 /
| 2024-11-12 5:31:37 PM | Chg. -0.180 | Volume | Bid9:57:01 PM | Ask9:57:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 6.440CHF | -2.72% | 441,245 Turnover: 3.11 mill. |
-Bid Size: 700 | -Ask Size: 62 | 90.42 mill.CHF | - | - |
Assets
| 2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 0.0000 | 0.0000 | 0.0000 | .0400 | 2.6910 | ||||||
| Intangible Assets | 35.2000 | 19.6000 | 30.8000 | 192.3000 | 162.9150 | ||||||
| Long-Term Investments | 0.0000 | 0.0000 | .4000 | 0.0000 | - | ||||||
| Fixed Assets | 35.2000 | 19.6000 | 31.2000 | 196.6000 | 166.2150 | ||||||
| Inventories | 0.0000 | 0.0000 | 0.0000 | .4000 | .2270 | ||||||
| Accounts Receivable | 0.0000 | 0.0000 | 0.0000 | 1.3000 | 1.3210 | ||||||
| Cash and Cash Equivalents | .4000 | .2000 | 38.1000 | 44.8000 | 19.2370 | ||||||
| Current Assets | .4000 | .3000 | 46.9000 | 55 | 22.5830 | ||||||
| Total Assets | 35.6000 | 19.9000 | 78 | 251.6000 | 188.7980 | ||||||
Liabilities
| 2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | .1000 | .3000 | 1.4000 | 1.7000 | 1.6250 | ||||||
| Long-term debt | - | - | - | .4000 | 2.2480 | ||||||
| Liabilities to Banks | 0.0000 | 0.0000 | .9000 | 1.7000 | - | ||||||
| Provisions | 7.5000 | 2.7000 | 4.3000 | 57.1000 | 31.7390 | ||||||
| Liabilities | 14.3000 | 4.5000 | 11 | 70.1000 | 43.3810 | ||||||
| Share Capital | 20.9000 | 21.1000 | 32.5000 | 44.1000 | - | ||||||
| Total Equity | 21.3000 | 14.3000 | 67 | 181.5000 | 145.4170 | ||||||
| Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 35.6000 | 19.9000 | 78 | 251.6000 | 188.7980 | ||||||
Income Statement
| 2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | .6000 | 0.0000 | 0.0000 | 3.3000 | 16 | ||||||
| Depreciation (total) | - | - | - | - | 30.2840 | ||||||
| Operating Result | -.5000 | -12.1000 | -9.1000 | -34.3000 | -52.0400 | ||||||
| Interest Income | - | - | - | - | -2.2760 | ||||||
| Income Before Taxes | -.4000 | -12.2000 | -6.3000 | -35.5000 | - | ||||||
| Income Taxes | 0.0000 | 4.7000 | -1.5000 | .8000 | 3.5260 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -.4000 | -7.5000 | -7.8000 | -34.3000 | -50.7900 | ||||||
Per Share
Cash Flow
| 2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -.6000 | -.7000 | -18.3000 | -35.7000 | -24.1260 | ||||||
| Cash Flow from Investing Activities | 0.0000 | 0.0000 | 3 | -30.3000 | -7.9990 | ||||||
| Cash Flow from Financing | .7000 | .6000 | 58.2000 | 67.7000 | 6.4170 | ||||||
| Decrease / Increase in Cash | .1000 | -.1000 | 43 | 1.7000 | - | ||||||
| Employees | - | - | - | - | - | ||||||
